https://scholars.lib.ntu.edu.tw/handle/123456789/533625
標題: | Cost-effectiveness of drug-eluting stents in patients with stable coronary artery disease | 作者: | CHI-SHENG HUNG Cheng, Chia-Ling CHIA-LUN CHAO HSIEN-LI KAO MING-FONG CHEN Lin, Neng-Pai |
關鍵字: | Bare metal stent; Cost-effectiveness; Drug-eluting stent; Percutaneous transluminal coronary angioplasty | 公開日期: | 二月-2011 | 出版社: | Elsevier B.V. | 卷: | 110 | 期: | 2 | 起(迄)頁: | 109-114 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Background/Purpose: Drug-eluting stents (DESs) have been shown to reduce in-stent restenosis and target vessel revascularization (TVR) in large clinical trials. We conducted this study to elucidate the differences in the cost and clinical outcome of DESs and bare metal stents (BMSs). Methods: We retrospectively analyzed the clinical data and costs of patients with stable angina treated with coronary stents from September 2003 to January 2005 at the National Taiwan University Hospital, Taipei, Taiwan. Results: We enrolled 186 patients treated with DESs and 194 patients treated with BMSs. The use of DESs is associated with a lower rate of TVR compared with that with BMSs (12% vs. 22%, p = 0.011). Compared with the BMS group, the overall costs were significantly higher in the DES group (NT$352,495 ± 140,408 vs. NT$298,947 ± 131,289, p < 0.001). The incremental cost to avoid one TVR at 2 years was NT$546,444 (95% confidence interval: NT$151,071-2,565,793). Conclusion: The use of DESs reduces the rate of TVR at 2 years after intervention, but is probably not cost-effective compared with BMSs in patients with stable coronary artery disease. ? 2011 Elsevier & Formosan Medical Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955612521&doi=10.1016%2fS0929-6646%2811%2960017-X&partnerID=40&md5=116219cfc280fc5df40c42374f2fe513 https://scholars.lib.ntu.edu.tw/handle/123456789/533625 |
ISSN: | 0929-6646 | DOI: | 10.1016/S0929-6646(11)60017-X | SDG/關鍵字: | adult; article; bare metal stent; controlled study; coronary artery disease; cost benefit analysis; drug eluting stent; female; human; major clinical study; male; stable angina pectoris; treatment outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。